Trials / Completed
CompletedNCT00735839
V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Single Dose of Merck S. Aureus Vaccine (V710) in Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Male
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate the safety and immunogenicity of V710 in Japanese male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | V710 | V710 vaccination (60 mcg, 0.5 ml) single injection on Day 1 |
| BIOLOGICAL | Placebo | Saline placebo (0.5 ml) single injection on Day 1 |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-08-15
- Last updated
- 2015-12-21
- Results posted
- 2012-06-26
Source: ClinicalTrials.gov record NCT00735839. Inclusion in this directory is not an endorsement.